Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors
Crossref DOI link: https://doi.org/10.1007/s13555-022-00878-9
Published Online: 2023-01-02
Published Print: 2023-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Martin, George http://orcid.org/0000-0002-8197-0740
Funding for this research was provided by:
Bristol-Myers Squibb
Text and Data Mining valid from 2023-01-02
Version of Record valid from 2023-01-02
Article History
Received: 1 August 2022
Accepted: 14 December 2022
First Online: 2 January 2023